Sex-based differences in survival after liver transplantation for colorectal cancer liver metastases: A multivariable analysis

This multicentre retrospective study analysed survival outcomes in 82 patients undergoing liver transplantation for colorectal liver metastases across seven US and European centres. Several factors, including female sex, high carcinoembryonic antigen levels, right-sided colorectal cancer, larger tumours, KRAS mutation, pN2-positive CRC, number of nodules, and no prior liver therapy, were linked to poorer outcomes. The study questions current prognostic models and selection criteria, emphasizing the need for more accurate tools to guide decision-making in patients with colorectal liver metastases.

Authors

Institutions

Publication Details

Journal
JHEP Reports
Published
2025-06-27
DOI
https://doi.org/10.1016/j.jhepr.2025.101505
Citations
4
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
5.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex-based differences in survival after liver transplantation for colorectal cancer liver metastases: A multivariable analysis

Jacopo Lanari, Morten Hagness, Umberto Cillo, Mohammad Alì Mansournia et al.
4 citations
JHEP Reports
Hepatocellular Carcinoma Treatment and Prognosis
5.29
article

Sex-based differences in survival after liver transplantation for colorectal cancer liver metastases: A multivariable analysis

Jacopo Lanari, Morten Hagness, Umberto Cillo, Mohammad Alì Mansournia, Matteo Cescon, Federico Aucejo, Ilaria Billato, Roberto Hernandez‐Alejandro, Svein Dueland, Koji Tomiyama, Bassam Estfan, Samuele Iesari, Vincenzo Mazzaferro, Matteo Serenari, Carlo Sposito, Pål‐Dag Line, Laurent Coubeau, Alessandro Vitale, Alessandro Rovetta
article en
4 citations

Abstract

This multicentre retrospective study analysed survival outcomes in 82 patients undergoing liver transplantation for colorectal liver metastases across seven US and European centres. Several factors, including female sex, high carcinoembryonic antigen levels, right-sided colorectal cancer, larger tumours, KRAS mutation, pN2-positive CRC, number of nodules, and no prior liver therapy, were linked to poorer outcomes. The study questions current prognostic models and selection criteria, emphasizing the need for more accurate tools to guide decision-making in patients with colorectal liver metastases.

JHEP ReportsVol. 7(10)
Oslo University Hospital (NO), Cliniques Universitaires Saint-Luc (BE), Cleveland Clinic (US), Statistics Korea (KR), University of Padua (IT), University of Oslo (NO), University of Milan (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), University of Rochester Medical Center (US), IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Tehran University of Medical Sciences (IR), UCLouvain (BE)
Good health and well-being
Openalex Percentile: Top 4%
Hepatocellular Carcinoma Treatment and Prognosis
5.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.